These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 27884714)

  • 1. Carrier particle design for stabilization and isolation of drug nanoparticles.
    Tierney T; Bodnár K; Rasmuson Å; Hudson S
    Int J Pharm; 2017 Feb; 518(1-2):111-118. PubMed ID: 27884714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carrier particle mediated stabilization and isolation of valsartan nanoparticles.
    Kumar A; Davern P; Hodnett BK; Hudson SP
    Colloids Surf B Biointerfaces; 2019 Mar; 175():554-563. PubMed ID: 30579056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fast dissolution of poorly water soluble drugs from fluidized bed coated nanocomposites: Impact of carrier size.
    Azad M; Moreno J; Bilgili E; Davé R
    Int J Pharm; 2016 Nov; 513(1-2):319-331. PubMed ID: 27639622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of solubility, antioxidant ability and bioavailability of taxifolin nanoparticles by liquid antisolvent precipitation technique.
    Zu Y; Wu W; Zhao X; Li Y; Wang W; Zhong C; Zhang Y; Zhao X
    Int J Pharm; 2014 Aug; 471(1-2):366-76. PubMed ID: 24882039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physical properties of griseofulvin-lipid nanoparticles in suspension and their novel interaction mechanism with saccharide during freeze-drying.
    Kamiya S; Kurita T; Miyagishima A; Itai S; Arakawa M
    Eur J Pharm Biopharm; 2010 Mar; 74(3):461-6. PubMed ID: 20018239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid nanoparticles: drug localization is substance-specific and achievable load depends on the size and physical state of the particles.
    Kupetz E; Bunjes H
    J Control Release; 2014 Sep; 189():54-64. PubMed ID: 24933601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of dry nanosuspension with highly spontaneous dispersible characteristics to develop solubilized formulation for poorly water-soluble drugs.
    Niwa T; Miura S; Danjo K
    Pharm Res; 2011 Sep; 28(9):2339-49. PubMed ID: 21626059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comminution of ibuprofen to produce nano-particles for rapid dissolution.
    Plakkot S; de Matas M; York P; Saunders M; Sulaiman B
    Int J Pharm; 2011 Aug; 415(1-2):307-14. PubMed ID: 21683776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing various techniques to produce micro/nanoparticles for enhancing the dissolution of celecoxib containing PVP.
    Homayouni A; Sadeghi F; Varshosaz J; Garekani HA; Nokhodchi A
    Eur J Pharm Biopharm; 2014 Sep; 88(1):261-74. PubMed ID: 24952357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carrier characteristics influence the kinetics of passive drug loading into lipid nanoemulsions.
    Göke K; Bunjes H
    Eur J Pharm Biopharm; 2018 May; 126():132-139. PubMed ID: 28807819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fast drying of biocompatible polymer films loaded with poorly water-soluble drug nano-particles via low temperature forced convection.
    Susarla R; Sievens-Figueroa L; Bhakay A; Shen Y; Jerez-Rozo JI; Engen W; Khusid B; Bilgili E; Romañach RJ; Morris KR; Michniak-Kohn B; Davé RN
    Int J Pharm; 2013 Oct; 455(1-2):93-103. PubMed ID: 23911341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous and scalable process for water-redispersible nanoformulation of poorly aqueous soluble APIs by antisolvent precipitation and spray-drying.
    Hu J; Ng WK; Dong Y; Shen S; Tan RB
    Int J Pharm; 2011 Feb; 404(1-2):198-204. PubMed ID: 21056643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and in vitro/in vivo evaluation of fenofibrate nanocrystals.
    Zuo B; Sun Y; Li H; Liu X; Zhai Y; Sun J; He Z
    Int J Pharm; 2013 Oct; 455(1-2):267-75. PubMed ID: 23876497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and characterization of hydroxypropyl methyl cellulose films containing stable BCS Class II drug nanoparticles for pharmaceutical applications.
    Sievens-Figueroa L; Bhakay A; Jerez-Rozo JI; Pandya N; Romañach RJ; Michniak-Kohn B; Iqbal Z; Bilgili E; Davé RN
    Int J Pharm; 2012 Feb; 423(2):496-508. PubMed ID: 22178619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aminoclay-lipid hybrid composite as a novel drug carrier of fenofibrate for the enhancement of drug release and oral absorption.
    Yang L; Shao Y; Han HK
    Int J Nanomedicine; 2016; 11():1067-76. PubMed ID: 27042061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and evaluation of raloxifene-loaded solid dispersion nanoparticle by spray-drying technique without an organic solvent.
    Tran TH; Poudel BK; Marasini N; Chi SC; Choi HG; Yong CS; Kim JO
    Int J Pharm; 2013 Feb; 443(1-2):50-7. PubMed ID: 23318367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cryogenic liquids, nanoparticles, and microencapsulation.
    Purvis T; Vaughn JM; Rogers TL; Chen X; Overhoff KA; Sinswat P; Hu J; McConville JT; Johnston KP; Williams RO
    Int J Pharm; 2006 Oct; 324(1):43-50. PubMed ID: 16814968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efavirenz Dissolution Enhancement IV-Antisolvent Nanocrystallization by Sonication, Physical Stability, and Dissolution.
    Sartori GJ; Prado LD; Rocha HVA
    AAPS PharmSciTech; 2017 Nov; 18(8):3011-3020. PubMed ID: 28493004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous production of fenofibrate solid lipid nanoparticles by hot-melt extrusion technology: a systematic study based on a quality by design approach.
    Patil H; Feng X; Ye X; Majumdar S; Repka MA
    AAPS J; 2015 Jan; 17(1):194-205. PubMed ID: 25344439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation of itraconazole nanococrystals and evaluation of their bioavailability in dogs.
    De Smet L; Saerens L; De Beer T; Carleer R; Adriaensens P; Van Bocxlaer J; Vervaet C; Remon JP
    Eur J Pharm Biopharm; 2014 May; 87(1):107-13. PubMed ID: 24388913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.